iShares Biotechnology ETF
306 hedge funds and large institutions have $4.42B invested in iShares Biotechnology ETF in 2014 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 81 increasing their positions, 117 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
31% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 117
35% less call options, than puts
Call options by funds: $439M | Put options by funds: $675M
Holders
306
Holding in Top 10
14
Calls
$439M
Puts
$675M
Top Buyers
| 1 | +$88.3M | |
| 2 | +$72.4M | |
| 3 | +$55.9M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22.8M |
| 5 |
HI
Honeywell International
Charlotte,
North Carolina
|
+$19.3M |
Top Sellers
| 1 | -$251M | |
| 2 | -$236M | |
| 3 | -$75.1M | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$74.7M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$52.7M |